
Department of Surgery (Division of General Surgery)
Position: Consultant
ORCID: 0000-0002-7294-4831
T +43 1 40400 56210
gerd.jomrich@meduniwien.ac.at
Keywords
Barrett Esophagus; Carcinoma, Pancreatic Ductal; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Fibroblast Growth Factors; Gastrectomy; Gastroesophageal Reflux; Inflammation; Neoadjuvant Therapy; Pancreatic Cancer; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pancreatitis; Receptors, Fibroblast Growth Factor; Translational Medical Research
Research group(s)
- Gastro-esophageal cancer program
Members: - Pancreatic surgery
Head: Martin Schindl
Research Area: Body composition and inflammation in pancreatic neoplasms.
Members: - Upper Gastrointestinal Research and Service
Head: Sebastian Schoppmann
Members:
Research interests
- Expression of Fibroblast Growth Factors and its Receptors in (neoadjuvantly treated) Esophageal and Pancreatic Cancer
- Prognostic Value of preoeprative Laboratory Results in Esophageal and Pancreatic Cancer
- Biobanking: Establishing a Biobank for Upper-GI and Pancreatic Malignancies
- Perioperative stress-induced biomarkers on stress signaling receptors in Esophageal and Pancreatic Cancer patients
Techniques, methods & infrastructure
- Upper-GI Biobank
- Pancreatic Cancer Biobank
- Analyzing Esophageal and Pancreatic Cancer RNASeq Data from TCGA (The Cancer Genome Atlas)
- Immunohistochemistry (IHC)
- Quantitative RT-PCR
- Retrospective Clinical Studies
Selected publications
- Jomrich, G. et al., 2019. High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma. Annals of Surgical Oncology, 26(4), pp.976–985. Available at: http://dx.doi.org/10.1245/s10434-019-07186-1.
- Jomrich, G. et al., 2018. MK2 and ETV1 Are Prognostic Factors in Esophageal Adenocarcinomas. Journal of Cancer, 9(3), pp.460–468. Available at: http://dx.doi.org/10.7150/jca.22310.
- Jomrich, G. & Schoppmann, S., 2015. Targeting HER 2 and angiogenesis in gastric cancer. Expert Review of Anticancer Therapy, 16(1), pp.111-122. Available at: http://dx.doi.org/10.1586/14737140.2016.1121110.
- Jomrich, G. et al., 2019. Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection. Journal of Gastrointestinal Surgery. Available at: http://dx.doi.org/10.1007/s11605-019-04187-z.
- Kollmann, D. et al., 2018. PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma. OncoImmunology, 7(6), p.e1435226. Available at: http://dx.doi.org/10.1080/2162402X.2018.1435226.